Value demonstration for:
















Biotech
0%
MedTech
0%
Pharma
0%
>90% never make it.
Most biotech startups fail before ever seeing a patient. Clinical setbacks, funding gaps, and regulatory complexity stop them before launch. Only 1 in 10 candidates becomes a real product.
75-80% fail to scale.
Getting a CE mark or FDA approval is just the beginning. Many medtech solutions never gain clinical traction or commercial adoption. Technical success doesn't always lead to market success.
Only 1 in 20 drugs makes it.
From discovery to approval, the pipeline is brutal. Most candidates fail in clinical trials or don't deliver enough value to reach the market. It's a long road, and most don't finish.
The problem isn't always the science.
The problem is to clearly show the impact of your product to EVERY stakeholder
Schedule a demo to see how X can drive your product's development and market success.
At Medip Analytics, we help MedTech and Life Sciences companies overcome the final, most difficult hurdle: Adoption. Many groundbreaking innovations never reach the patient, not because of a lack of clinical efficacy, but because they fail to navigate the complexities of local healthcare systems.
Traditional effectiveness studies and generic health economic evaluations are no longer sufficient to convince modern decision-makers. Payers, providers, and policymakers are overwhelmed with data, yet they remain stuck on one critical question:
"What is the real impact for my specific organization?"
When global evidence fails to answer this localized question, an "Impact Gap" is created. This gap leads to hesitation, budget rejection, and stalled market uptake.
Medip Analytics closes the gap by translating global clinical success into local financial and operational reality. We move beyond "one-size-fits-all" data to provide every stakeholder with a personalized business case.
Many groundbreaking medical innovations fail to achieve widespread adoption, not due to a lack of efficacy, but because generic data fails to demonstrate localized value which hampers adoption. Healthcare professionals (HCPs), payers, and policymakers all require specific answers to one critical question:
What is the real impact in my specific setting?
Our advanced Health Economic Software empowers MedTech, Biotech, and pharmaceutical companies to translate global clinical evidence into local relevance. We bridge the gap between innovation and adoption by simulating specific patient populations and care pathways and calculate the cost-effectiveness, return on investment (ROI), societal consequences and workforce impact.
Designed for conversations with healthcare professionals, payers and policymakers: intuitive visuals grounded in rigorous modeling, kept current with the latest data—so HCPs, managers and payers quickly see the value of your medical product in their context.
Show clinicians what changes in their ward, pathway and outcomes.
Easily update the software with new data from your tests or incorporate findings from recent landmark studies.
Demonstrate the environmental impact of your product and enhance the sustainability of healthcare for future generations.
Guide HCPs from evidence to impact in minutes.
Bridge clinical outcomes with costs and resources.
Clinically credible. Methodologically robust.
Surface early clinical value propositions that resonate with KOLs and HCPs.
Optimize value by calculating optimal thresholds and innovation costs.
Lead with HCP-ready views: outcomes, workflow and budget impact by ward/service.
Schedule a demo to see how Health Economic Software can improve the market uptake of your products.
Use our Health Economic Software across diseases to answer the HCP question: what’s the real impact in my setting? We focus on oncology, infectious disease and neurology, and are expanding continuously.
See how to turn your evidence into HCP-ready insights on outcomes, pathways and workload.